Johns Hopkins Health Alert
News on BPH from Johns Hopkins
UPDATE
As part of our ongoing effort to ensure that this website is up to date, we have determined that the information in the article News on BPH from Johns Hopkins is no longer current, and has therefore been removed.
Thank you.
Posted in Prostate Disorders on February 22, 2007
Reviewed June 2011
Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer
Notify Me
Would you like us to inform you when we post new Prostate Disorders Health Alerts?
Comments
Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.
The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.
What are the bladder-related complications resulting from a high level of a protein from JM-27? Is there a cure for this complication?
Posted by: 264 | March 4, 2007 6:49 PM
I am in 60's and trying to be more properly diagnosed about the condition of my prostate and urinary tract. Following a spike in PSA , 30 days of antibiotics, PSA successfully lowered/returned PSA levels from 6 to 4 and after another 2 weeks w/out any, to 3. However, I still have alot/all of the symptoms as before and a very high score on the standard verbal questionaire.
After reading your alert, I need reliable information that I can share with my physician to discuss obtaining the PM-27 test you have discovered to diagnose severity of BPH and possibility of bladder complications now or later. However, I am also confused about the relationship of the amount of JM-27 (high or low) with the severity of BPH as stated by the remarks received in the above comments. On the one hand higher levels indicate more severe form, and later it says that men with low levels had worse form of disease. Please explain for benefit of all.
Secondly, how do I go about obtaining this test now from medical facilities outside the U.S. (or inside U.S when visiting there) if this test is refused (likely because not yet FDA approved) by my U.S. primary care facility overseas? If available now, approximately how much should it cost in the U.S.? Finally, if I am able to obtain a blood sample from an approved U.S. gov't/civilian hospital/clinic, where can this be sent for proper analysis (if such a facility cannot/ will not analyse itself)? If approprite, also please provide a listing or a few locations in DELMARVA area if available.
Thank you for your kindness and timely information. JHH has been and is truly the best!
Posted by: Sanidad | March 9, 2007 6:19 AM
Still await with others your response to clarification of your own previous alert. Also where can I make arrangements for PM-27 test and analysis? Do you have a point of contact with email address to obtain clarification and add'l information (not medical advice) if you cannot help us at this site? Do you comment on others comments? Difficult if not impossible to get through by phone. Toll free not available overseas. Lost for what to do next to get help! Thx
Posted by: Sanidad | March 21, 2007 11:18 AM
As the Press Release explains, the M-27 diagnostic test is not yet FDA approved and research is still in its early stages. The next issue of the Johns Hopkins Prostate Bulletin will feature an interview with Dr. Gertzenberg about the biomarker. If you're interested, I suggest you consider subscribing to the Bulletin so you can access this information.
Additionally, this comment area is not the place to ask Johns Hopkins for advice. If you have a question you can write to us at customerservice@johnshopkinshealthalerts.com. This area is designed as a place where readers can share experiences and knowledge.
Posted by: Marjorie | March 21, 2007 3:05 PM
Post a Comment
Already a subscriber?
Login
New to Johns Hopkins Health Alerts?
I am confused if high JM-27 indicates "BPH is more severe and likely to lead to bladder-related complications" (see paragraph 1 of the press release. Or "men with higher levels of JM-27 had the less severe form of BPH, whereas men with low levels of JM-27 had the worse form of the disease" (see paragraph 6).
So which is it? Is high levels of JM-27 good, or bad......
Posted by: dd | February 24, 2007 8:57 AM